The case for an integrative model: Hypotheses and rationale for integrative MDMA-Assisted Psychotherapy (IMAP)
Rachel Yehuda, Amy Lehrner, Miryam Sperka, Tamar Glatman Zaretsky, Laura C. Pratchett, M. Mehmet Haznedar, Lauren Lepow
Psychedelics January 8, 2026 DOI: 10.1016/j.psyche.2026.100008 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Intervention | Integrative MDMA-Assisted Psychotherapy |
| Topics | Meditation MDMA Psychedelic-assisted therapy |
| Keywords | Mainstream Transpersonal Foundation evidence Experiential learning Integrative psychotherapy Therapeutic relationship Flexibility engineering Ethos Psychotherapist Empirical research Generalization Grounded theory Perspective graphical Divergence linguistics Humanistic psychology Premise Epistemology Presentation obstetrics Conceptualization Viewpoints |
| Citations | 2 |
| Key points | Proposes Integrative MDMA-Assisted Psychotherapy (IMAP) as a principle-guided, patient-driven model that combines humanistic and trauma-focused traditions to address limitations of the original MAPS manual's transpersonal concepts. |
Abstract
The original MAPS manual for MDMA-assisted therapy (MDMA-AT) opened a therapeutic frontier for PTSD. However, it drew critique for concepts—such as “inner healing intelligence” – that originated in transpersonal traditions rather than academic or empirically grounded clinical models. While many patients found the therapies helpful, these constructs were difficult to interpret and standardize. They lacked a clear foundation in trauma science, making them challenging to integrate into mainstream clinical practice. In response, we propose Integrative MDMA-Assisted Psychotherapy (IMAP), a principle-guided, patient-driven model rooted in both humanistic and trauma-focused psychotherapy traditions. IMAP diverges from directive, technique-centered psychotherapy models by offering a flexible, relationally attuned approach that supports the nonlinear, emergent processes characteristic of MDMA-assisted therapy. This flexibility is grounded in orienting principles that enable clinicians to make real-time decisions without relying on a predetermined agenda. IMAP incorporates contemporary theories of PTSD and selectively draws from evidence-based trauma interventions, while retaining the ethos of experiential approaches. Its divergence from both protocol-driven PTSD treatments and atheoretical, non-directive psychedelic models invites empirical investigation to identify which therapeutic elements are essential in psychedelic contexts.